Grace Gene Therapy

About

Funding history · 1 round · — total

Headcount over time

Q&A

What is Grace Gene Therapy's primary focus?

Grace Gene Therapy is an Israeli startup focused on developing a gene therapy treatment for Parkinson's disease, utilizing a chemogenetic agent that selectively targets diseased brain regions.

When was Grace Gene Therapy founded?

Grace Gene Therapy was founded in 2024.

Where is Grace Gene Therapy headquartered?

Grace Gene Therapy is headquartered in Nazareth, Israel.

How many employees does Grace Gene Therapy currently have?

Grace Gene Therapy has 7 employees, falling within the 1-10 employee bucket.

What is the current product stage of Grace Gene Therapy?

Grace Gene Therapy is currently in the R&D product stage.

What is Grace Gene Therapy's primary sector?

Grace Gene Therapy's primary sector is Health Tech & Life Sciences.

Who are the co-founders of Grace Gene Therapy?

The co-founders of Grace Gene Therapy are Fadi Assaf, who also serves as CEO, and Yitzhak Schiller.

What is Grace Gene Therapy's approach to treating Parkinson's disease?

Grace Gene Therapy's approach involves using a chemogenetic agent that selectively targets the diseased region of the brain with a precise biological neuromodulator, operating independently of the dopaminergic system, and utilizing DREADDs (Designer Receptors Exclusively Activated by Designer Drugs).

Team · 2

Fadi Assaf

Founder · CEO & Co-founder

Yitzhak Schiller

Founder · Co-founder

Sectors & technology

Tags